Chang Chiann

Rivaroxaban versus no anticoagulation for post-discharge thromboprophylaxis after hospitalisation for COVID-19 (MICHELLE): an open-label, multicentre, randomised, controlled trial

Eduardo Ramacciotti, Leandro Barile Agati, Daniela Calderaro et al. · The Lancet · 2021 · 245 citations · Full text

Thrombosis, Hematology, Patient Safety +8

A wavelet analysis for time series

Chang Chiann, Pedro A. Morettin · Journal of nonparametric statistics · 1998 · 102 citations

Engineering, Wavelet Analysis, Wavelet Spectral Analysis +11

Pharmacist–physician collaborative care model for patients with uncontrolled type 2 diabetes in Brazil: results from a randomized controlled trial

Patrícia Melo Aguiar, Cláudio Henrique P. da Silva, Chang Chiann et al. · Journal of Evaluation in Clinical Practice · 2016 · 56 citations

A comparative analysis of biopharmaceutics classification system and biopharmaceutics drug disposition classification system: A cross-sectional survey with 500 bioequivalence studies

Rodrigo Cristofoletti, Chang Chiann, Jennifer Dressman et al. · Journal of Pharmaceutical Sciences · 2013 · 46 citations · Full text

Drug Safety, Bioequivalence, Medicine +9

Effect of pH, mucin and bovine serum on rifampicin permeability through Caco‐2 cells

José Eduardo Gonçalves, Mariane B. Fernandes, Chang Chiann et al. · Biopharmaceutics & Drug Disposition · 2012 · 23 citations · Full text

Pharmaceutical Science, Immunology, Antimicrobial Chemotherapy +17